Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 28 | 2024 | 21156 | 1.200 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2021 | 259 | 0.770 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2018 | 1149 | 0.730 |
Why?
|
Fertility | 2 | 2021 | 772 | 0.550 |
Why?
|
Ovariectomy | 1 | 2018 | 614 | 0.510 |
Why?
|
Uterine Hemorrhage | 1 | 2015 | 240 | 0.450 |
Why?
|
Ovary | 1 | 2018 | 960 | 0.440 |
Why?
|
Amenorrhea | 1 | 2015 | 484 | 0.390 |
Why?
|
Organs at Risk | 1 | 2012 | 368 | 0.350 |
Why?
|
Radiation Injuries | 2 | 2013 | 1205 | 0.310 |
Why?
|
BRCA2 Protein | 3 | 2023 | 802 | 0.300 |
Why?
|
BRCA1 Protein | 4 | 2023 | 1158 | 0.290 |
Why?
|
Receptor, erbB-2 | 5 | 2023 | 2586 | 0.290 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2013 | 811 | 0.280 |
Why?
|
Quality of Life | 5 | 2024 | 13497 | 0.280 |
Why?
|
Gastrointestinal Tract | 1 | 2012 | 840 | 0.270 |
Why?
|
Endometrial Neoplasms | 2 | 2013 | 1382 | 0.270 |
Why?
|
Preoperative Care | 1 | 2015 | 2257 | 0.270 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9425 | 0.220 |
Why?
|
Neoadjuvant Therapy | 4 | 2023 | 2896 | 0.210 |
Why?
|
Receptors, Estrogen | 3 | 2020 | 2243 | 0.200 |
Why?
|
Lymphatic Metastasis | 2 | 2021 | 2930 | 0.200 |
Why?
|
Pregnancy Rate | 2 | 2020 | 655 | 0.180 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2012 | 2040 | 0.170 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11843 | 0.170 |
Why?
|
Live Birth | 2 | 2020 | 516 | 0.170 |
Why?
|
Prospective Studies | 13 | 2024 | 54914 | 0.160 |
Why?
|
Age Factors | 6 | 2024 | 18478 | 0.160 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 582 | 0.140 |
Why?
|
Female | 31 | 2024 | 396943 | 0.140 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5709 | 0.140 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2022 | 3550 | 0.140 |
Why?
|
Receptors, Progesterone | 1 | 2021 | 1145 | 0.140 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2022 | 1536 | 0.130 |
Why?
|
Germ-Line Mutation | 2 | 2023 | 1884 | 0.130 |
Why?
|
Adult | 21 | 2024 | 223542 | 0.120 |
Why?
|
Mastectomy | 2 | 2020 | 1852 | 0.120 |
Why?
|
Goserelin | 1 | 2015 | 126 | 0.120 |
Why?
|
Confidence Intervals | 1 | 2020 | 2932 | 0.120 |
Why?
|
Young Adult | 9 | 2024 | 60045 | 0.120 |
Why?
|
Age Distribution | 1 | 2020 | 2881 | 0.120 |
Why?
|
Contraceptive Agents, Female | 1 | 2015 | 121 | 0.120 |
Why?
|
Leuprolide | 1 | 2015 | 313 | 0.110 |
Why?
|
Piperazines | 1 | 2024 | 2546 | 0.110 |
Why?
|
Tamoxifen | 1 | 2018 | 968 | 0.110 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1092 | 0.110 |
Why?
|
Pregnancy Outcome | 2 | 2021 | 2959 | 0.110 |
Why?
|
Humans | 32 | 2024 | 768451 | 0.100 |
Why?
|
Lymphatic Irradiation | 1 | 2012 | 115 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2888 | 0.100 |
Why?
|
Adaptation, Psychological | 1 | 2022 | 2665 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1395 | 0.090 |
Why?
|
Pregnancy | 6 | 2024 | 30179 | 0.090 |
Why?
|
Adolescent | 7 | 2024 | 89168 | 0.090 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2012 | 882 | 0.090 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2012 | 350 | 0.090 |
Why?
|
Anxiety | 2 | 2022 | 4655 | 0.090 |
Why?
|
Duodenum | 1 | 2012 | 495 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9687 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3472 | 0.070 |
Why?
|
Germ Cells | 2 | 2022 | 641 | 0.070 |
Why?
|
Genetic Testing | 1 | 2021 | 3586 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2010 | 0.070 |
Why?
|
Survivors | 3 | 2022 | 2381 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4931 | 0.070 |
Why?
|
Combined Modality Therapy | 2 | 2022 | 8559 | 0.070 |
Why?
|
Cisplatin | 1 | 2012 | 1661 | 0.070 |
Why?
|
Intestine, Small | 1 | 2012 | 1218 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12096 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2021 | 81834 | 0.060 |
Why?
|
Aorta | 1 | 2012 | 2046 | 0.060 |
Why?
|
Central Nervous System Neoplasms | 1 | 2013 | 928 | 0.060 |
Why?
|
Colon | 1 | 2012 | 1804 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2024 | 59680 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6242 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9507 | 0.050 |
Why?
|
Time Factors | 3 | 2020 | 40271 | 0.050 |
Why?
|
Decision Making | 1 | 2017 | 3961 | 0.050 |
Why?
|
Social Support | 2 | 2024 | 2195 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 30028 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2020 | 65409 | 0.050 |
Why?
|
North America | 1 | 2024 | 1292 | 0.040 |
Why?
|
Phthalazines | 1 | 2023 | 396 | 0.040 |
Why?
|
Aged | 6 | 2024 | 171520 | 0.040 |
Why?
|
Cohort Studies | 2 | 2020 | 41797 | 0.040 |
Why?
|
Medicare | 1 | 2018 | 6881 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18048 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13708 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 906 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 998 | 0.040 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2021 | 502 | 0.030 |
Why?
|
Mutation | 1 | 2021 | 30243 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6856 | 0.030 |
Why?
|
Paclitaxel | 1 | 2023 | 1737 | 0.030 |
Why?
|
Body Image | 1 | 2020 | 644 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2020 | 961 | 0.030 |
Why?
|
Life Expectancy | 1 | 2022 | 1249 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 708 | 0.030 |
Why?
|
Middle Aged | 6 | 2024 | 223418 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1076 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1556 | 0.030 |
Why?
|
Child | 3 | 2021 | 80863 | 0.030 |
Why?
|
Fear | 1 | 2021 | 1494 | 0.030 |
Why?
|
Anorexia | 1 | 2013 | 152 | 0.030 |
Why?
|
Weight Gain | 1 | 2022 | 2357 | 0.020 |
Why?
|
Body Weight | 1 | 2022 | 4630 | 0.020 |
Why?
|
Mammography | 1 | 2022 | 2436 | 0.020 |
Why?
|
Weight Loss | 1 | 2022 | 2710 | 0.020 |
Why?
|
Nausea | 1 | 2013 | 682 | 0.020 |
Why?
|
Vomiting | 1 | 2013 | 655 | 0.020 |
Why?
|
United States | 1 | 2018 | 73121 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3123 | 0.020 |
Why?
|
Alopecia | 1 | 2013 | 416 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2022 | 11249 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2013 | 2925 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2969 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2024 | 4636 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5909 | 0.020 |
Why?
|
Headache | 1 | 2013 | 1260 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15460 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 74915 | 0.010 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2013 | 1097 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6537 | 0.010 |
Why?
|
Depression | 1 | 2020 | 8235 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24311 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6657 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36497 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42623 | 0.010 |
Why?
|
Male | 1 | 2013 | 364781 | 0.000 |
Why?
|
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_